EQRx Inc.

06/14/2022 | Press release | Distributed by Public on 06/14/2022 05:03

EQRx Announces Acceptance of Marketing Authorization Application by the UK's Medicines and Healthcare Products Regulatory Agency for Aumolertinib in EGFR-Mutated Non-small Cell[...]